SLYND (DROSPIRENONE) — FDA Approval NDA211367 (EXELTIS USA INC)
SLYND (DROSPIRENONE) — FDA Approval NDA211367 (EXELTIS USA INC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: SLYND; Active ingredients: DROSPIRENONE; Application number: NDA211367.
| Brand name | SLYND |
|---|---|
| Active ingredients | DROSPIRENONE |
| Application number | NDA211367 |
| Sponsor | EXELTIS USA INC |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20190523 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →